Publicaciones en colaboración con investigadores/as de Universidad Católica San Antonio (9)

2024

  1. Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

    Neurology and Therapy, Vol. 13, Núm. 1, pp. 153-164

2022

  1. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders

    Neurologia, Vol. 37, Núm. 3, pp. 178-183

  2. Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30)

    Multiple Sclerosis and Related Disorders, Vol. 66

2021

  1. Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis

    Stem Cell Research, Vol. 53

2020

  1. Erratum to “Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm” [Neurologia. 2020;35(6):357–362] (Neurología (2020) 35(6) (357–362), (S0213485320301389), (10.1016/j.nrl.2020.06.001))

    Neurologia

  2. Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis

    Clinical Therapeutics, Vol. 42, Núm. 5, pp. e87-e99

  3. Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules

    Multiple Sclerosis and Related Disorders, Vol. 44

  4. Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm

    Neurologia, Vol. 35, Núm. 6, pp. 357-362

2019

  1. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test)

    Multiple Sclerosis and Related Disorders, Vol. 28, pp. 50-56